logo
A Common Virus Causes Cancer, but Most Americans Are Clueless About It

A Common Virus Causes Cancer, but Most Americans Are Clueless About It

Gizmodo2 days ago
The human papillomavirus (HPV) is a major source of cancer that's now almost entirely preventable through vaccination. But sobering research out today shows that Americans are largely in the dark about HPV and its many health risks, much less the HPV vaccine.
Researchers at the Medical University of South Carolina conducted the study, which examined nationally representative survey data. A third of Americans don't know that the virus exists, they found, while most who do know are still unaware it can cause more than one type of cancer besides cervical cancer. People in certain regions of the country, particularly Midwest and Southern states, were even less aware of HPV, which likely helps explain why vaccination rates are lagging in these areas, the researchers say.
'Some of these states have the lowest HPV vaccine coverage in the nation, which could be a reason why we are observing these differences,' lead study author Ashvita Garg, a public health researcher at MUSC, told Gizmodo.
There are over 200 different types of HPV, which is spread through skin contact (including sexual contact). Some types are low-risk, only causing unseemly but harmless warts along our skin or genitals. Other high-risk types can linger in the body and cause damaging changes to normal cells that raise their risk of becoming cancerous.
HPV is the leading cause of cervical cancer, accounting for nearly all cases. But high-risk HPV infections are also primarily responsible for several other kinds of cancer, including vaginal and vulvar cancers in women, penile cancer in men, and oral cancer in both men and women. In fact, HPV-related oral cancer is more common in men than it is in women. All told, about 40,000 HPV-caused cancers occur annually in the U.S.
Today's vaccines can prevent up to nine different high-risk types of HPV, but the vaccination rate remains relatively low in many parts of the world, the U.S. included. The researchers sought to better understand just how aware people are about the virus and the value of vaccination.
The researchers studied data from the Health Information National Trends Survey (HINTS), a project run by the National Cancer Institute that regularly measures Americans' knowledge of health and cancer-related information. Their sample ultimately included almost 23,000 responses collected between 2017 and 2022.
Based on the survey data, around 34% of Americans nationally were ignorant about the existence of HPV, and 37% were ignorant about the HPV vaccine. Of those who did know about the virus, 71% didn't know that it can cause oral cancer, and 28% didn't know it caused cervical cancer. Ignorance of HPV and the vaccine was especially high (over 40%) in seven states, including Kansas, Nebraska, and Illinois in the Midwest, as well as Mississippi, Arkansas, and Alabama in the South. These same states have some of the lowest HPV vaccination rates in the country, and about 62% of all HPV-related cancers occur in the Southern and Midwestern U.S., the authors note.
'Additionally, the gap between awareness that HPV causes oral cancer was notably larger compared to the awareness that HPV causes cervical cancer, highlighting the undervaluation of the importance of HPV vaccination in males,' Garg said. The team's findings were published Thursday in JAMA Oncology.
Some countries have already started to effectively eliminate cervical and other HPV-related cancers through widespread HPV vaccination, but the U.S. is still lagging well behind. Overall, only around 57% of American teenagers in 2023 received the HPV vaccine as recommended, well below the 80% target goal that health officials are hoping to reach by 2030. The researchers say that much more effort is needed to improve people's knowledge of HPV and its dangers.
'Improving HPV awareness would require a multifaceted approach, such as public education campaigns, improving patient-provider communication, and community and school-based outreach programs,' Garg said.
Unfortunately, the federal government may not be so interested in HPV prevention these days. Robert F. Kennedy Jr., the current health secretary, has regularly spread misinformation about the HPV vaccine and even referred to Merck's HPV shot, Gardasil, as the 'most dangerous vaccine ever invented.'
All that said, Garg and her team at MUSC are still dedicated to improving HPV vaccine coverage in their neck of the woods.
'Beyond examining the HPV-related cancer burden and mortality, we are also investigating the uptake and delivery of HPV prevention modalities and understanding prevention behaviors across the US,' she said. 'MUSC is also actively involved in public health outreach, particularly in South Carolina, where initiatives like the HPV Vaccination Van are helping to improve education and access to HPV vaccination.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Anti-vaccine group that Robert F. Kennedy Jr. founded files lawsuit against him over vaccine safety task force
Anti-vaccine group that Robert F. Kennedy Jr. founded files lawsuit against him over vaccine safety task force

CNN

time13 minutes ago

  • CNN

Anti-vaccine group that Robert F. Kennedy Jr. founded files lawsuit against him over vaccine safety task force

Vaccines Children's health Federal agenciesFacebookTweetLink Follow A nonprofit anti-vaccine group founded by Robert F. Kennedy Jr. said it is funding a lawsuit against him, in his capacity as secretary of the US Department of Health and Human Services, for failing to establish a task force to promote the development of safer childhood vaccines. 'Our first priority will ALWAYS be children's health. Sec. Kennedy has FAILED 'to establish a task force dedicated to making childhood vaccines safer, as mandated by federal law,' so we WILL be holding him accountable,' Children's Health Defense said Tuesday in a post on X. The tactic is one familiar to both parties. When Kennedy was head of Children's Health Defense, he filed dozens of lawsuits against corporations and government agencies, usually over vaccines. 'It's difficult to know how much of this is performative,' Dr. Peter Hotez, who co-directs the Center for Vaccine Development at Texas Children's Hospital in Houston, said in an email. 'The steady stream of pseudoscience policies and propaganda pushed out of the Humphrey Building in Washington DC are both straight out of playbook from both RFK jr and CHD. As far as I can tell there is no real daylight between the two.' The National Childhood Vaccine Injury Act of 1986 directs the HHS secretary to establish a task force consisting of the director of the National Institutes of Health, the commissioner of the Food and Drug Administration and the director of the Centers for Disease Control and Prevention. The NIH director is designated as chair. According to an article posted Monday on Children's Health Defense's news site, in the years since the act was passed, no HHS secretary – including Kennedy – has ever reported to Congress on steps taken to make vaccines safer. 'This is part of the 1986 act itself,' Children's Health Defense CEO Mary Holland said in the article. 'That no secretary has done so since the passage of this law is a blow to the rule of law. I hope and trust that the current secretary will fulfill his obligation to Congress's mandate.' The task force was indeed created, but it was short-lived, issuing its final report in 1998. Since then, Kennedy has used the absence of the panel to mischaracterize the government's efforts to ensure the safety of vaccines. He's floated the idea of reviving the panel – or one like it – on vaccine safety for years. Children's Health Defense says attorney Ray Flores, its senior outside counsel, filed the lawsuit. Kennedy filed a similar suit in 2018 after a Freedom of Information Act request failed to produce any of the reports that are supposed to be filed under the Act, including the 1998 report. HHS has not responded to CNN's request for comment about the new lawsuit. Dorit Reiss, a professor of law at UC Law San Francisco, also said the lawsuit 'looks performative.' 'It may give Kennedy cover for convening this task force that he may already want to convene. It may well be collusion,' she said in an email. 'To me, this looks like a way to give political cover to something the Secretary may want to do anyway (and can do without anything). The government has answers to this lawsuit, but may not want to. 'Even if it does not include the people in the [National Childhood Vaccine Injury Act], there are multiple federal committees that routinely look at vaccine safety and how to make vaccines safer. It's something that gets a lot of attention,' Reiss wrote. Correction: A previous version of this story incorrectly described who filed the lawsuit against HHS Secretary Robert F. Kennedy Jr. The lawsuit was filed by attorney Ray Flores and Children's Health Defense says it's funding the lawsuit.

Kansas coach Bill Self undergoes heart procedure
Kansas coach Bill Self undergoes heart procedure

Yahoo

time38 minutes ago

  • Yahoo

Kansas coach Bill Self undergoes heart procedure

Kansas men's basketball coach Bill Self was transported to Lawrence Memorial Hospital on Thursday after he 'experienced some concerning symptoms,' according to a statement from Kansas Athletics. Self had two stents inserted during a heart procedure that 'went very well,' and he is expected to make a full recovery. 'He is in good spirits and expects to be released from the hospital soon.' The university did not disclose any information regarding a timetable for Self's recovery or whether he will miss the upcoming basketball season. Self previously underwent a heart procedure and had two stents placed to treat blocked arteries in 2023. The veteran coach had experienced chest tightness and had concerns about his balance after watching shooting as his team was preparing for a Big 12 tournament quarterfinal game that year. He recovered and was present at NCAA Tournament practices, but did not fully return to coaching on the sideline for games until the following season. Who is Bill Self? Bill Self has spent the past 22 seasons as Kansas' head basketball coach, winning the national championship in 2008 and 2022. The Jayhawks have qualified for the NCAA Tournament 21 times during Self's tenure, only missing the 2020 season when the tournament was canceled due to the COVID-19 pandemic. He has compiled a 624-156 overall record during his time at Kansas. When does Kansas open the 2025-26 season? Kansas has exhibition games scheduled against Louisville (Oct. 24) and Fort Hays State (Oct. 28) before opening the season against Green Bay on Nov. 3 and North Carolina on Nov. 7. This article originally appeared on USA TODAY: Bill Self update: Kansas men's basketball coach has heart procedure

Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy
Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy

Business Insider

time44 minutes ago

  • Business Insider

Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy

Shares in biopharmaceutical company Precigen (PGEN) rocketed higher today after the U.S. Food and Drug Administration gave the green light to a therapy to treat a rare respiratory disease. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The approval of the therapy, called Papzimeos, is the first treatment for the condition to receive the health regulator's nod. Fatal Tumors Papzimeos has been approved to treat recurrent respiratory papillomatosis (RRP) — a condition that causes growth of wart-like tumors in the respiratory tract due to human papillomavirus (HPV) infection. RRP can lead to severe voice disturbance, a compromised airway, and recurrent post-obstructive pneumonias. Precigen estimates that there are about 27,000 adult RRP patients in the U.S. RRP can be fatal as there is no cure and the current standard-of-care is repeated surgeries. However, despite being removed in these surgeries, the growth has a tendency to return. 'For more than a century, since RRP was first recognized as a distinct disease, patients have had to rely on repeated surgeries to manage this relentless condition. Today marks a historic turning point. With the landmark FDA approval all adult RRP patients are now eligible for access to the first and only approved therapy that targets the root cause of the disease,' said Helen Sabzevari, PhD, President and CEO of Precigen. Analyst Upgrade Simon Best, associate professor of Otolaryngology at Johns Hopkins Hospital, added: 'Everybody is anxiously awaiting a new treatment for this disease. The patients are and the surgeons are. There's nothing more frustrating than doing a surgery and then having the patient come back six months later.' The approval was based on an early-to-mid-stage study data that showed 51% of patients required no surgeries in the 12 months after the treatment. upgraded Precigen to Neutral from Underweight on the news. It cited the removal of Precigen's 'major regulatory overhang' and its revenue potential for the upgrade. It estimates that peak sales for the drug in the U.S. to be about $250 million. Precigen is certainly making strides when it comes to its financials – as can be seen below. Precigen recently reported a Q2 net loss of $26.6 million, a significant improvement from the $58.8 million loss in the same period last year. Total revenues for the quarter were $856,000, up from $717,000 in the previous year, driven by increased service revenues. Is PGEN a Good Stock to Buy Now? On TipRanks, PGEN has a Hold consensus based on 2 Buy, 1 Hold and 1 Sell ratings. Its highest price target is $6. PGEN stock's consensus price target is $4.50, implying a 143.24% upside.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store